Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    19897179 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy
Conditions: Depressive Symptoms;   Impaired Cognition;   Electroconvulsive Therapy
Interventions: Drug: ketamine and propofol;   Drug: propofol  and normal saline
2 Unknown † A Study of Ketamine as an Antidepressant
Condition: Major Depressive Episode
Interventions: Drug: Ketamine;   Drug: Saline or Midazolam (active placebo)
3 Completed Continuation Ketamine in Major Depression
Condition: Major Depressive Disorder
Interventions: Drug: Lithium;   Drug: Ketamine
To Top

† Indicates status has not been verified in more than two years